SPONSOR
Prof. Wolfgang Janni
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Breast Cancer
Prof. Wolfgang Janni is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Prof. Wolfgang Janni
How many clinical trials has Prof. Wolfgang Janni sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Prof. Wolfgang Janni, of which 2 are actively recruiting participants. These trials cover conditions including Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Prof. Wolfgang Janni research focus on?
Prof. Wolfgang Janni clinical trials span Breast Cancer. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Prof. Wolfgang Janni clinical trial?
To participate in a Prof. Wolfgang Janni trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Prof. Wolfgang Janni trials with current recruitment status updated daily.
Clinical Trials by Prof. Wolfgang Janni
NCT05658172
Recruiting
Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer
Breast Cancer
NCT06643585 Phase 3
Recruiting
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology